Surv BioPharma

Website

Team & Investors

Leadership, board of directors, and investment partners

Executives

Board Members

Investors

Total Funding

$17.2M

Investors

9 investors across all rounds

DCI Partners

Fujita Innovation Capital

Higin Capital

Japan Venture Capital

Kagoshima Development

+4 more investors

Explore More Data

Detailed analysis for Surv BioPharma

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

Surv BioPharma Leadership & Investors

Surv BioPharma is led by a team of experienced leaders. The company has attracted investment from 9 institutional and strategic investors.

Who Has Invested in Surv BioPharma?

Surv BioPharma has raised $17.2M from 9 investors including venture capital firms, private equity investors, and strategic partners.

Investment Opportunity

Accredited investors can access Surv BioPharma shares through secondary market platforms like Premier Alternatives, joining the company's existing institutional investor base.